BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$67.94
+2.33%Leverage
- Debt / equity
- -0.99x
- Net debt / equity
- -0.72x
- Debt / assets
- 2.05x
- Debt / EBITDA
- -4.08x
- Net debt / EBITDA
- -2.97x
Liquidity & coverage
- Current ratio
- 1.23x
- Quick ratio
- 1.17x
- Cash ratio
- 0.81x
- Interest coverage
- -6.05x
- EBITDA / interest
- -6.80x
- Working capital
- $202.5M
Cash & dividend
- FCF / debt
- -0.18x
- Cash flow / debt
- -0.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026